Song Yanling, Song Qiujie, Li Ling, Xu Jinfeng, Liu Xingqiang
Department of Ophthalmology, People's Hospital of Dongying, Dongying, Shandong 257091, P.R. China.
Exp Ther Med. 2018 Sep;16(3):2506-2510. doi: 10.3892/etm.2018.6441. Epub 2018 Jul 13.
This study aims to investigate the effect of intravitreal injection of ranibizumab on glaucoma rat model and its effect on optic nerve injury. A total of 125 SD rats were used to establish glaucoma models. Of them, 80 well-established model were selected, 40 of which received intravitreal injections of ranibizumab and were assigned to the observation group. The remaining 40 received no drug and were assigned to the control group. After rats were sacrificed at the time-points, the retina was harvested. Numbers of retinal ganglion cells (RGCs) were counted under a fluorescence microscope. In the meantime, levels of interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) in peripheral blood and aqueous humor were determined. The levels of IL-6 and VEGF in peripheral blood and aqueous humor decreased gradually over the time of treatment in the observation group (P<0.05). In the control group the levels of IL-6 in peripheral blood and aqueous humor increased gradually over time (P<0.05). At the same time-point, the IL-6 level was higher in the control group than that in the observation group (P<0.05). The VEGF level in the observation group was lower in day 21 than that in day 7 (P<0.05). The VEGF level was higher in the control group than that in the observation group (P<0.05). The number of RGCs in the observation group increased gradually over the time of treatment, and there were significant differences in the number of RGCs between day 7 and 14, as well as day 14 and 21 (P<0.05). The number of RGCs in the control group decreased gradually over time (P<0.05). The levels of IL-6 and VEGF were all negatively correlated with the number of RGCs, and the correlation coefficient r and P-value were -0.743 and 0.012, and -0.675 and 0.022, respectively. Ranibizumab attenuated optic nerve injury by reducing levels of IL-6 and VEGF in peripheral blood and aqueous humor of glaucoma rat model.
本研究旨在探讨玻璃体内注射雷珠单抗对青光眼大鼠模型的影响及其对视神经损伤的作用。共使用125只SD大鼠建立青光眼模型。其中,选取80只成功建立模型的大鼠,将其中40只接受玻璃体内注射雷珠单抗,并分配至观察组。其余40只未接受药物治疗,分配至对照组。在各时间点处死大鼠后,采集视网膜。在荧光显微镜下计数视网膜神经节细胞(RGCs)的数量。同时,测定外周血和房水中白细胞介素-6(IL-6)和血管内皮生长因子(VEGF)的水平。观察组外周血和房水中IL-6和VEGF水平在治疗过程中逐渐降低(P<0.05)。对照组外周血和房水中IL-6水平随时间逐渐升高(P<0.05)。在同一时间点,对照组的IL-6水平高于观察组(P<0.05)。观察组第21天的VEGF水平低于第7天(P<0.05)。对照组的VEGF水平高于观察组(P<0.05)。观察组RGCs数量在治疗过程中逐渐增加,第7天与第14天、第14天与第21天之间RGCs数量存在显著差异(P<0.05)。对照组RGCs数量随时间逐渐减少(P<0.05)。IL-6和VEGF水平均与RGCs数量呈负相关,相关系数r和P值分别为-0.743和0.012,以及-0.675和0.022。雷珠单抗通过降低青光眼大鼠模型外周血和房水中IL-6和VEGF水平减轻视神经损伤。